{"database": "openregs", "table": "documents", "rows": [["FDA-2009-P-0597-0022", "FDA", "FDA-2009-P-0597", "Tab 54/Exhibit 54 - \"Thomas, et al., Inhaled Corticosteroids for Asthma: Impact of Practice Level Device Switching on Asthma Controls\" - [GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2009-12-29T05:00:00Z", 2009, 12, null, null, "2009-12-30T00:43:07Z", null, 0, 0, "0900006480a6ccd6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2009-P-0597-0022"], "units": {}, "query_ms": 0.40682312101125717, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}